|
業務類別
|
-- |
|
業務概覽
|
Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products. |
| 公司地址
| 697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124 |
| 電話號碼
| +61 390920480 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.neurenpharma.com |
| 員工數量
| 11 |
| Mr. Jonathan Pilcher |
Director, Chief Executive Officer and Managing Director |
-- |
02/04/2025 |
|
|
| Ms. Dianne Angus |
Independent Director |
02/04/2025 |
| Dr. Jenny Harry |
Independent Director |
02/04/2025 |
| Mr. Joe Basile |
Independent Director |
02/04/2025 |
| Mr. Jonathan Pilcher |
Director, Chief Executive Officer and Managing Director |
02/04/2025 |
| Mr. Patrick Donald Davies, M.B.A. |
Non-Executive Chairman of the Board |
02/04/2025 |
|
|
|
|
